Curia Expands Cell Line Development Offering with CHOZN Platform
ALBANY, N.Y., June 20 (Korea Bizwire) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and its clients to use the CHOZN® GS-/- cell line for production of therapeutic proteins and [...]










